Lyell Immunopharma, Inc. Common Stock
LYEL
LYEL: Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).
moreShow LYEL Financials
Recent trades of LYEL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by LYEL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on LYEL's company Twitter account
Number of mentions of LYEL in WallStreetBets Daily Discussion
Recent insights relating to LYEL
Recent picks made for LYEL stock on CNBC
ETFs with the largest estimated holdings in LYEL
Flights by private jets registered to LYEL